Business Context and Reporting Period
Company: Lucid Diagnostics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 7, 2022
Reporting Period: Single event date (March 7, 2022)
Business Context: The filing serves as a Regulation FD disclosure to announce an upcoming business update conference call scheduled for March 28, 2022, at 4:30 PM EDT.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural announcement regarding a future conference call and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document solely announces the scheduling of a corporate event.
Guidance, Outlook, and Management Commentary
- Upcoming Event: Management will host a business update conference call on Monday, March 28, 2022.
- Disclosure Status: The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other disclosure documents unless expressly stated.
- Exhibits: A press release (Exhibit 99.1) containing the announcement is attached to the report.
Investor Verification Checklist
- Verify the date and time of the upcoming conference call (March 28, 2022, 4:30 PM EDT).
- Review the attached press release (Exhibit 99.1) for any additional details not summarized in the 8-K text.
- Monitor the company's investor relations website for the conference call webcast link and replay availability.
- Note that this filing does not contain financial results; investors should refer to the most recent 10-K or 10-Q for financial data.